Elizabeth Soria-Castro Selected Research

Clofibrate

1/2019	Clofibrate Treatment Decreases Inflammation and Reverses Myocardial Infarction-Induced Remodelation in a Rodent Experimental Model.
8/2016	Peroxisome proliferator-activated receptor-α stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle.
5/2015	PPARα Stimulation Modulates Myocardial Ischemia-induced Activation of Renin-Angiotensin System.
10/2012	Clofibrate PPARα activation reduces oxidative stress and improves ultrastructure and ventricular hemodynamics in no-flow myocardial ischemia.
9/2010	Effect of clofibrate on vascular reactivity in a model of high blood pressure secondary to aortic coarctation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth Soria-Castro Research Topics

Disease

7	Hypertension (High Blood Pressure) 01/2021 - 07/2008
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2021 - 07/2008
5	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 10/2012
4	COVID-19 01/2022 - 07/2020
4	Myocardial Infarction 01/2020 - 12/2016
3	Proteinuria 09/2020 - 01/2013
3	Inflammation (Inflammations) 07/2020 - 10/2012
3	Ischemia 01/2020 - 05/2015
3	Aortic Coarctation 08/2016 - 02/2010
2	Marfan Syndrome (Marfan's Syndrome) 01/2022 - 12/2019
2	Albuminuria 04/2021 - 12/2011
2	Hypoxia (Hypoxemia) 01/2021 - 12/2011
2	Pneumonia (Pneumonitis) 01/2021 - 07/2020
2	Insulin Resistance 12/2016 - 07/2008
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Body Weight (Weight, Body) 04/2021
1	Necrosis 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Sepsis (Septicemia) 07/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2020
1	Acute Lung Injury 07/2020
1	Aortic Aneurysm (Aneurysm, Aortic) 12/2019
1	Ventricular Remodeling 01/2019
1	Glomerulonephritis 01/2018
1	Reperfusion Injury 01/2017
1	Infarction (Infarctions) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2016
1	Uremia 03/2016
1	Cardiotoxicity 03/2016
1	Aneurysm (Aneurysms) 01/2014
1	Turner Syndrome (Turner's Syndrome) 01/2014
1	Nephrosis 01/2013
1	Kidney Diseases (Kidney Disease) 01/2013
1	Herpes Zoster 01/2013

Drug/Important Bio-Agent (IBA)

6	AntioxidantsIBA 01/2022 - 02/2010
6	salicylhydroxamic acid (SHAM)IBA 01/2020 - 10/2012
5	Clofibrate FDA Link 01/2019 - 09/2010
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
4	Triglycerides (Triacylglycerol)IBA 04/2021 - 12/2011
3	Insulin (Novolin)FDA Link 04/2021 - 12/2011
3	CreatinineIBA 04/2021 - 01/2013
3	Fenofibrate (CiL)FDA LinkGeneric 01/2021 - 12/2016
3	Angiotensin IIIBA 01/2020 - 02/2010
3	PPAR alphaIBA 01/2020 - 02/2010
2	Fibrillin-1IBA 01/2022 - 12/2019
2	HDL CholesterolIBA 01/2021 - 12/2016
2	LipidsIBA 01/2021 - 03/2016
2	CytokinesIBA 01/2021 - 07/2020
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2020 - 01/2016
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020 - 05/2015
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2016 - 10/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2016 - 01/2013
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	NADP (NADPH)IBA 01/2022
1	3-nitrotyrosineIBA 09/2021
1	Caspase 9IBA 09/2021
1	Gold Colloid (Colloidal Gold)IBA 09/2021
1	LeptinIBA 04/2021
1	Oleic Acid (Oleate)IBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Essential Fatty AcidsIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	SteroidsIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	CholesterolIBA 09/2020
1	Oxygen (Dioxygen)IBA 07/2020
1	des-Asp(1)-des-Arg(2)-Ile(5)- angiotensin IIIBA 01/2020
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020
1	angiotensin I (1-7)IBA 01/2020
1	Neprilysin (Neutral Endopeptidase)IBA 01/2020
1	Angiotensin IIIIBA 01/2020
1	AntibodiesIBA 12/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2018
1	Caveolin 3IBA 01/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017
1	Type 1 Angiotensin ReceptorIBA 12/2016
1	Vasodilator Agents (Vasodilators)IBA 12/2016
1	Fibric Acids (Fibrates)IBA 12/2016
1	Captopril (Capoten)FDA LinkGeneric 08/2016
1	Aryldialkylphosphatase (Paraoxonase)IBA 03/2016
1	ApolipoproteinsIBA 03/2016
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 03/2016
1	Collagen Type IV (Type IV Collagen)IBA 01/2014
1	nephrinIBA 01/2013
1	CateninsIBA 01/2013
1	Urea (Carbamide)FDA LinkGeneric 01/2013
1	podocalyxinIBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 01/2013
1	Arachidonic Acid (Vitamin F)IBA 12/2011
1	Protein Isoforms (Isoforms)IBA 12/2011
1	Sucrose (Saccharose)IBA 12/2011

Therapy/Procedure

2	Therapeutics 07/2020 - 12/2016
1	Artificial Respiration (Mechanical Ventilation) 07/2020
1	Length of Stay 07/2020
1	Operative Surgical Procedures 12/2019
1	Intravenous Administration 03/2016